Related Experiment Video
Updated: Jan 8, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Beyond the blockade: unmet needs in systemic targeted atopic dermatitis therapy
Li Zhang1,2,3, Ge Peng3, Mingyue Wang1,2
1Department of Dermatology, The First Hospital of China Medical University, Liaoning, China.
New systemic therapies have improved atopic dermatitis treatment, but challenges remain in achieving lasting control and managing side effects. Future research aims for more effective, convenient treatments and better patient outcomes.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Atopic dermatitis (AD) management has advanced with systemic targeted therapies.
- These therapies modulate key inflammatory cytokine signaling pathways.
Purpose of the Study:
- To review current systemic targeted therapies for atopic dermatitis.
- To identify persistent unmet needs and outline future research directions.
Main Methods:
- Literature review of current atopic dermatitis treatments.
- Analysis of efficacy, limitations, and future therapeutic strategies.
Main Results:
- Janus kinase (JAK) inhibitors and interleukin-4/interleukin-13 (IL-4/IL-13) pathway inhibitors demonstrate significant efficacy.
- Unmet needs include stable disease control, managing nonresponders, side effects, and pruritus.
Conclusions:
- Despite advancements, challenges in atopic dermatitis treatment persist.
- Future directions focus on dual/multitarget drugs, improved formulations, novel targets, and patient-reported outcomes.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Clinical Applications of Epidermal Stem Cells
Allergic Drug Reactions
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

